Pam R. Taub, MD, FACC, is Associate Professor of Medicine in the Division of Cardiovascular Medicine, Department of Medicine, at the University of California (UC), San Diego. She is also the founder and Director of the Step Family Foundation Cardiovascular Rehabilitation and Wellness Center.
Her clinical practice focuses on preventive cardiology, lipidology, as well as women's cardiovascular health. She is active in clinical/translational research and has received funding from the National Institutes of Health (Principal Investigator on R01 grant), Department of Defense, and American Heart Association. Her research focuses on assessing the impact of pharmacologic intervention and lifestyle changes on cardiometabolic disease. She is conducting research studies evaluating biomarkers for cardiovascular risk factor stratification, studying the effects of daily fasting in improving cardiometabolic parameters and examining the effects of a compound in dark chocolate (epicatechin) on mitochondrial function/cellular bioenergetics and exercise capacity, Dr. Taub is widely published and has authored numerous publications in top peer-reviewed journals.
Dr. Taub received her MD from Boston University School of Medicine. She completed her residency in internal medicine at the University of Washington Medical Center in Seattle and her fellowship in cardiovascular medicine at UC San Diego. She is board certified in internal medicine, cardiovascular disease,.
Pam R. Taub, MD, FACC, is Associate Professor of Medicine in the Division of Cardiovascular Medicine, Department of Medicine, at the University of California (UC), San Diego. She is also the founder and Director of the Step Family Foundation Cardiovascular Rehabilitation and Wellness Center.
Her clinical practice focuses on preventive cardiology, lipidology, as well as women's cardiovascular health. She is active in clinical/translational research and has received funding from the National Institutes of Health (Principal Investigator on R01 grant), Department of Defense, and American Heart Association. Her research focuses on assessing the impact of pharmacologic intervention and lifestyle changes on cardiometabolic disease. She is conducting research studies evaluating biomarkers for cardiovascular risk factor stratification, studying the effects of daily fasting in improving cardiometabolic parameters and examining the effects of a compound in dark chocolate (epicatechin) on mitochondrial function/cellular bioenergetics and exercise capacity, Dr. Taub is widely published and has authored numerous publications in top peer-reviewed journals.
Dr. Taub received her MD from Boston University School of Medicine. She completed her residency in internal medicine at the University of Washington Medical Center in Seattle and her fellowship in cardiovascular medicine at UC San Diego. She is board certified in internal medicine, cardiovascular disease,.